Javier Perez-Hernandez

Dr. Javier Perez-Hernandez

"T-cell tolerance, Biomarkers and Therapies in Type 1 Diabetes" team, Université de Paris, Institut Cochin, CNRS, INSERM, 75014 Paris, France
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2021 in Hypertension
Verified
Journal Article
Closed access
PDF file
Javier Perez-HernandezJavier Perez-Hernandez
Javier Perez-Hernandez
ARAngela L. Riffo-Campos
Angela L. Riffo-Campos
Ana OrtegaAna Ortega
Ana Ortega
OMOlga Martínez
Olga Martínez
DPDaniel Perez-Gil
Daniel Perez-Gil
Raquel CortesRaquel Cortes
Raquel Cortes
Urinary albumin excretion (UAE) is a marker of cardiovascular risk and renal damage in hypertension. MicroRNAs (miRNAs) packaged into exosomes function as paracrine effectors in cell communication and the kidney is not exempt. This study aimed to state an exosomal miRNA profile/signature associated to hypertension with increased UAE and the impact of profibrotic TGF-β1 (transforming growth factor β1) on exosomes miRNA release. Therefore, exosomes samples from patients with hypertension with/without UAE were isolated and characterized. Three individual and unique small RNA libraries from each subject were prepared (total plasma, urinary, and plasma-derived exosomes) for next-generation sequencing profiling. Differentially expressed miRNAs were over-represented in Kyoto Encyclopedia of Genes and Genomes pathways, and selected miRNAs were validated by real-time quantitative polymerase chain reaction in a confirmation cohort. Thus, a signature of 29 dysregulated circulating miRNAs was identified in UAE hypertensive subjects, regulating 21 pathways. Moreover, changes in the levels of 4 exosomes-miRNAs were validated in a confirmation cohort and found associated with albuminuria. In particular miR-26a, major regulator of TGF-β signaling, was found downregulated in both type of exosomes when compared with healthy controls and to hypertension normoalbuminurics ( P <0.01). Similarly, decreased miR-26a levels were found in podocyte-derived exosomes after TGF-β stress. Our results revealed an exosomes miRNA signature associated to albuminuria in hypertension. In particular, exosomes miR-26a seemed to play a key role in the regulation of TGF-β, a relevant effector in podocyte damage. These findings support the use of exosomes miRNAs as biomarkers of cardiovascular risk progression and therapeutic tools in early kidney damage.

20 January 2021 in Sustainable Energy & Fuels
Verified
Journal Article
Closed access
PDF file
NKNoufal Kandoth
Noufal Kandoth
Javier Perez-HernandezJavier Perez-Hernandez
Javier Perez-Hernandez
EPEmilio Palomares-Gil
Emilio Palomares-Gil
JLJulio Lloret-Fillol
Julio Lloret-Fillol
Photoinduced organic transformations have stimulated the organic chemistry community to develop light-driven renewed reaction methodologies, which in many cases are complementary to standard thermal catalysis.

17 January 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
ACAlexia Carré
Alexia Carré
FSFatoumata Samassa
Fatoumata Samassa
ZZZhicheng Zhou
Zhicheng Zhou
Javier Perez-HernandezJavier Perez-Hernandez
Javier Perez-Hernandez
CLChristiana Lekka
Christiana Lekka
RMRoberto Mallone
Roberto Mallone
Interferon (IFN)-α is the earliest cytokine signature observed in individuals at risk for type 1 diabetes (T1D), but the effect of IFN-α on the antigen repertoire of HLA Class I (HLA-I) in pancreatic β-cells is unknown. Here we characterize the HLA-I antigen presentation in resting and IFN-α-exposed β-cells and find that IFN-α increases HLA-I expression and expands peptide repertoire to those derived from alternative mRNA splicing, protein cis-splicing and post-translational modifications. While the resting β-cell immunopeptidome is dominated by HLA-A-restricted peptides, IFN-α largely favors HLA-B and only marginally upregulates HLA-A, translating into increased HLA-B-restricted peptide presentation and activation of HLA-B-restricted CD8+ T cells. Lastly, islets of patients with T1D show preferential HLA-B hyper-expression when compared with non-diabetic donors, and islet-infiltrating CD8+ T cells reactive to HLA-B-restricted granule peptides are found in T1D donors. Thus, the inflammatory milieu of insulitis may skew the autoimmune response toward alternative epitopes presented by HLA-B, hence recruiting T cells with a distinct repertoire that may be relevant to T1D pathogenesis.

8 March 2024 in Science Advances
Verified
Journal Article
Open access
FVFederica Vecchio
Federica Vecchio
ACAlexia Carré
Alexia Carré
DKDaniil Korenkov
Daniil Korenkov
ZZZhicheng Zhou
Zhicheng Zhou
PAPaola Apaolaza
Paola Apaolaza
RMRoberto Mallone
Roberto Mallone
Coxsackievirus B (CVB) infection of pancreatic β cells is associated with β cell autoimmunity and type 1 diabetes. We investigated how CVB affects human β cells and anti-CVB T cell responses. β cells were efficiently infected by CVB in vitro, down-regulated human leukocyte antigen (HLA) class I, and presented few, selected HLA-bound viral peptides. Circulating CD8 + T cells from CVB–seropositive individuals recognized a fraction of these peptides; only another subfraction was targeted by effector/memory T cells that expressed exhaustion marker PD-1. T cells recognizing a CVB epitope cross-reacted with β cell antigen GAD. Infected β cells, which formed filopodia to propagate infection, were more efficiently killed by CVB than by CVB-reactive T cells. Our in vitro and ex vivo data highlight limited CD8 + T cell responses to CVB, supporting the rationale for CVB vaccination trials for type 1 diabetes prevention. CD8 + T cells recognizing structural and nonstructural CVB epitopes provide biomarkers to differentially follow response to infection and vaccination.

Verified
Journal Article
Open access
PDF file
ARAngela L. Riffo-Campos
Angela L. Riffo-Campos
Javier Perez-HernandezJavier Perez-Hernandez
Javier Perez-Hernandez
Ana OrtegaAna Ortega
Ana Ortega
OMOlga Martínez
Olga Martínez
ACAna Flores Chova
Ana Flores Chova
Raquel CortesRaquel Cortes
Raquel Cortes
Non-coding RNA (ncRNA), released into circulation or packaged into exosomes, plays important roles in many biological processes in the kidney. The purpose of the present study is to identify a common ncRNA signature associated with early renal damage and its related molecular pathways. Three individual libraries (plasma and urinary exosomes, and total plasma) were prepared from each hypertensive patient (with or without albuminuria) for ncRNA sequencing analysis. Next, an RNA-based transcriptional regulatory network was constructed. The three RNA biotypes with the greatest number of differentially expressed transcripts were long-ncRNA (lncRNA), microRNA (miRNA) and piwi-interacting RNA (piRNAs). We identified a common 24 ncRNA molecular signature related to hypertension-associated urinary albumin excretion, of which lncRNAs were the most representative. In addition, the transcriptional regulatory network showed five lncRNAs (LINC02614, BAALC-AS1, FAM230B, LOC100505824 and LINC01484) and the miR-301a-3p to play a significant role in network organization and targeting critical pathways regulating filtration barrier integrity and tubule reabsorption. Our study found an ncRNA profile associated with albuminuria, independent of biofluid origin (urine or plasma, circulating or in exosomes) that identifies a handful of potential targets, which may be utilized to study mechanisms of albuminuria and cardiovascular damage.

10 March 2025 in Diabetes
Verified
Journal Article
Closed access
PAPouria Akhbari
Pouria Akhbari
Javier Perez-HernandezJavier Perez-Hernandez
Javier Perez-Hernandez
MRMark A. Russell
Mark A. Russell
SDShalinee Dhayal
Shalinee Dhayal
KLK. Afi Leslie
K. Afi Leslie
SRSarah Richardson
Sarah Richardson
HLA class I (HLA-I) molecules present intracellular antigenic peptides to CD8+ T cells during immune surveillance. In donors with type 1 diabetes, hyperexpression of HLA-I occurs in islets with residual insulin-producing β-cells as a hallmark of the disease. HLA-I hyperexpression is frequently detected beyond the islet boundary, forming a “halo.” We hypothesized that this halo may reflect the diffusion of soluble forms of HLA-I (sHLA-I) from the islets to the surrounding pancreatic parenchyma. To verify this, we assessed the expression of total, cell surface, and sHLA-I in β-cell lines and isolated human islets after treatment with interferon-α (IFN-α) and IFN-γ. Consistent with the expression patterns of HLA-I in situ, the β-cell lines and cultured human islets dramatically upregulated total and surface HLA-I when exposed to IFNs. Concomitantly, sHLA-I release was significantly increased. HLA-I released within extracellular vesicles and cleaved forms of HLA-I did not significantly contribute to the sHLA-I pool. Rather, IFNs upregulated mRNA splice variants lacking the transmembrane domain. Our findings suggest that β-cells respond to IFNs by upregulating cell-associated and soluble forms of HLA-I. Soluble HLA-I may play a role in modulating islet inflammation during the autoimmune attack. Article Highlights: Hyperexpression of cell-associated HLA class I (HLA-I) induced by interferons is a hallmark feature of the residual insulin-containing pancreatic islets of people with type 1 diabetes. Soluble forms of HLA-I have also been described and are increased in the blood of individuals with viral infections and autoimmune disease, including type 1 diabetes. We assessed whether β-cells release soluble HLA-I (sHLA-I) in response to interferons. We confirm that human β-cells release significant levels of sHLA-I, demonstrate that this increases after interferon exposure, and define the release mechanism. We propose that sHLA-I may affect the activity of infiltrating CD8+ T cells in type 1 diabetes.